207 related articles for article (PubMed ID: 26916836)
1. Donor-specific antibodies and liver transplantation.
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Kamar N
Hum Immunol; 2016 Nov; 77(11):1063-1070. PubMed ID: 26916836
[TBL] [Abstract][Full Text] [Related]
2. De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients.
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Cardeau-Desangles I; Guitard J; Dörr G; Milongo D; Suc B; Duffas JP; Alric L; Bureau C; Guilbeau-Frugier C; Rostaing L; Kamar N
Transpl Int; 2015 Dec; 28(12):1371-82. PubMed ID: 26303035
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
Delville M; Charreau B; Rabant M; Legendre C; Anglicheau D
Hum Immunol; 2016 Nov; 77(11):1055-1062. PubMed ID: 27237040
[TBL] [Abstract][Full Text] [Related]
4. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation.
Muro M; Legaz I
World J Gastroenterol; 2023 Feb; 29(5):766-772. PubMed ID: 36816626
[TBL] [Abstract][Full Text] [Related]
5. Humoral Response in Liver Allograft Transplantation: A Review of the Role of Anti-Human Leukocyte Antigen (HLA) Antibodies.
Muro M; Moya-Quiles MR; Mrowiec A
Curr Protein Pept Sci; 2016; 17(8):776-784. PubMed ID: 26916161
[TBL] [Abstract][Full Text] [Related]
6. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature.
Wozniak LJ; Naini BV; Hickey MJ; Bhattacharyya S; Reed EF; Busuttil RW; Farmer DG; Vargas JH; Venick RS; McDiarmid SV
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27597379
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.
Kheradmand T; Anthony TL; Harland RC; Testa G; Hart J; Renz J; Te HS; Marino SR
Hum Immunol; 2014 Jun; 75(6):578-83. PubMed ID: 24530823
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation.
Vandevoorde K; Ducreux S; Bosch A; Guillaud O; Hervieu V; Chambon-Augoyard C; Poinsot D; André P; Scoazec JY; Robinson P; Boillot O; Dubois V; Dumortier J
Liver Transpl; 2018 Aug; 24(8):1091-1100. PubMed ID: 29665189
[TBL] [Abstract][Full Text] [Related]
9. Increasing relevance of donor-specific antibodies in antibody-mediated rejection.
Zito A; Schena A; Grandaliano G; Gesualdo L; Schena FP
J Nephrol; 2013; 26(2):237-42. PubMed ID: 23475460
[TBL] [Abstract][Full Text] [Related]
10. Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.
Malard-Castagnet S; Dugast E; Degauque N; Pallier A; Soulillou JP; Cesbron A; Giral M; Harb J; Brouard S
Hum Immunol; 2016 Nov; 77(11):1076-1083. PubMed ID: 26546874
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E
World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation.
Papachristou M; Fylaktou A; Daoudaki M; Cholongitas E; Karampatakis T; Anastasiou A; Chatzika G; Makrovasili F; Vagiotas L; Karakasi K; Fouzas I
Transplant Proc; 2019 Mar; 51(2):424-428. PubMed ID: 30879557
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation.
Gerlach UA; Lachmann N; Sawitzki B; Arsenic R; Neuhaus P; Schoenemann C; Pascher A
Transpl Int; 2014 Mar; 27(3):280-9. PubMed ID: 24279605
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological relevance of antibodies in solid organ transplantation.
Mehra NK; Baranwal AK
Int J Immunogenet; 2016 Dec; 43(6):351-368. PubMed ID: 27870356
[TBL] [Abstract][Full Text] [Related]
15. Evolution of serum and intra-graft donor-specific anti-HLA antibodies in a patient with two consecutive liver transplantations.
Neau-Cransac M; Le Bail B; Guidicelli G; Visentin J; Moreau K; Quinart A; Boueilh A; Laurent C; Taupin JL
Transpl Immunol; 2015 Oct; 33(2):58-62. PubMed ID: 26321506
[TBL] [Abstract][Full Text] [Related]
16. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
17. Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure.
Rashidi-Alavijeh J; Heinold A; Willuweit K; Baba HA; Horn PA; Paul A; Witzke O; Gerken G; Herzer K
Z Gastroenterol; 2016 Jul; 54(7):647-52. PubMed ID: 27429102
[TBL] [Abstract][Full Text] [Related]
18. De novo donor specific antibodies and patient outcomes in renal transplantation.
DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA
Clin Transpl; 2011; ():351-8. PubMed ID: 22755430
[TBL] [Abstract][Full Text] [Related]
19. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.
O'Leary JG; Kaneku H; Jennings LW; Bañuelos N; Susskind BM; Terasaki PI; Klintmalm GB
Liver Transpl; 2013 Sep; 19(9):973-80. PubMed ID: 23780820
[TBL] [Abstract][Full Text] [Related]
20. Donor-specific human leukocyte antigen antibodies in intestinal transplantation.
Kaneku H; Wozniak LJ
Curr Opin Organ Transplant; 2014 Jun; 19(3):261-6. PubMed ID: 24811437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
